Cidara Therapeutics Inc (CDTX)
20.40
+2.95
(+16.91%)
USD |
NASDAQ |
Nov 22, 16:00
21.31
+0.91
(+4.46%)
After-Hours: 20:00
Cidara Therapeutics Shares Outstanding: 7.047M for Nov. 4, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 04, 2024 | 7.047M |
September 30, 2024 | 7.047M |
August 08, 2024 | 7.038M |
July 19, 2024 | 7.038M |
June 30, 2024 | 4.569M |
May 28, 2024 | 4.562M |
May 13, 2024 | 4.562M |
April 24, 2024 | 4.562M |
April 12, 2024 | 4.562M |
March 31, 2024 | 4.562M |
February 27, 2024 | 4.531M |
December 31, 2023 | 4.530M |
October 31, 2023 | 4.522M |
September 30, 2023 | 4.521M |
July 31, 2023 | 4.513M |
June 30, 2023 | 4.513M |
May 08, 2023 | 4.501M |
April 25, 2023 | 4.501M |
March 31, 2023 | 4.501M |
March 16, 2023 | 4.450M |
March 07, 2023 | 4.135M |
December 31, 2022 | 3.624M |
November 08, 2022 | 3.581M |
October 31, 2022 | 3.581M |
September 30, 2022 | 3.559M |
Date | Value |
---|---|
July 29, 2022 | 3.504M |
June 30, 2022 | 3.462M |
April 29, 2022 | 3.452M |
April 25, 2022 | 3.452M |
March 31, 2022 | 3.452M |
February 28, 2022 | 3.408M |
December 31, 2021 | 3.393M |
October 29, 2021 | 3.334M |
October 13, 2021 | 3.328M |
September 30, 2021 | 2.481M |
July 30, 2021 | 2.475M |
June 30, 2021 | 2.475M |
April 30, 2021 | 2.414M |
April 26, 2021 | 2.414M |
March 31, 2021 | 2.414M |
February 18, 2021 | 2.402M |
December 31, 2020 | 2.244M |
October 31, 2020 | 2.197M |
September 30, 2020 | 2.197M |
July 31, 2020 | 2.148M |
June 30, 2020 | 2.101M |
June 04, 2020 | 2.056M |
April 30, 2020 | 2.037M |
April 27, 2020 | 2.037M |
March 31, 2020 | 2.028M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.692M
Minimum
Dec 31 2019
7.047M
Maximum
Sep 30 2024
3.548M
Average
3.452M
Median
Mar 31 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Arbutus Biopharma Corp | 189.49M |
GlycoMimetics Inc | 64.48M |
FibroGen Inc | 100.77M |
Cue Biopharma Inc | 63.35M |